⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

RVTY

Revvity, Inc.

Healthcare · Diagnostics & Research

123.85USD

-3.2300 (-2.54%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1.29▼$1.31012
Next quarter$1.61▼$1.67012
Current year$5.35▲$5.25100
Next year$5.89▲$5.82103

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$1.22$1.41+0.19 (+15.9%)
2026-03-31$1.01$1.06+0.05 (+4.5%)
2025-12-31$1.58$1.7+0.12 (+7.8%)
2025-09-30$1.14$1.18+0.04 (+3.6%)

Wall Street coverage

81 ratings from 19 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
KeybancMaintainedOverweight$125 $165Sep 4, 2026
RBC CapitalInitiatedSector Perform$135Sep 1, 2026
Evercore ISI GroupMaintainedOutperform$125 $126Aug 5, 2026
Evercore ISI GroupMaintainedOutperform$110 $125Jul 6, 2026
BarclaysMaintainedEqual-Weight$95 $105May 7, 2026
JP MorganMaintainedNeutral$96 $90May 6, 2026
TD CowenMaintainedBuy$115 $120May 6, 2026
StifelMaintainedHold$110 $100May 6, 2026
BairdMaintainedOutperform$129 $125May 4, 2026
Goldman SachsMaintainedNeutral$110 $95Apr 14, 2026
BarclaysDowngraded from OverweightEqual-Weight$118 $95Apr 14, 2026
JP MorganMaintainedNeutral$105 $96Mar 31, 2026
JP MorganMaintainedNeutral$100 $105Feb 3, 2026
TD CowenMaintainedBuy$120 $124Feb 3, 2026
Evercore ISI GroupMaintainedOutperform$112 $118Feb 3, 2026
Wells FargoMaintainedEqual-Weight$107 $110Feb 3, 2026
BarclaysMaintainedOverweight$115 $118Feb 3, 2026
JefferiesMaintainedHold$100 $105Feb 3, 2026
BarclaysMaintainedOverweight$105 $115Dec 15, 2025
Wells FargoMaintainedEqual-Weight$102 $107Dec 15, 2025
Goldman SachsInitiatedNeutral$105Dec 9, 2025
BarclaysMaintainedOverweight$100 $105Oct 28, 2025
BairdMaintainedOutperform$122 $123Oct 28, 2025
GuggenheimInitiatedNeutral—Oct 16, 2025
Evercore ISI GroupMaintainedOutperform$108 $106Oct 7, 2025

Insider transactions

59 filings from 16 insiders · 14 buy / 3 sell over 6m

Officers and directors of RVTY, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
MICHAS ALEXANDROS PDirectorGiftindirect285——Aug 25, 2026
GOLDBERG JOEL SGeneral CounselGift27.8k——Aug 14, 2026
SINGH PRAHLAD RChief Executive OfficerGift67.3k——Aug 13, 2026
GONZALES ANITAOfficerSell85$109.48$9kJul 20, 2026
BARRETT PETERDirectorGrant2.3k——May 7, 2026
MICHAS ALEXANDROS PDirectorGrant2.7k——May 7, 2026
VOUNATSOS MICHEL PERICLESDirectorGrant2.3k——May 7, 2026
CHAPIN SAMUEL R.DirectorGrant2.3k——May 7, 2026
WITZ PASCALEDirectorGrant2.3k——May 7, 2026
KLOBUCHAR MICHAEL ADirectorGrant2.3k——May 7, 2026
VANDEBROEK SOPHIE VDirectorGrant2.3k——May 7, 2026
WITNEY FRANKLIN R. PH.D.DirectorGrant2.3k——May 7, 2026
MCMURRY-HEATH MICHELLEDirectorGrant2.3k——May 7, 2026
GONZALES ANITAOfficerSell80$92.80$7kApr 20, 2026
GONZALES ANITAOfficerGrant1.6k——Mar 16, 2026
GONZALES ANITAOfficerGrant1.7k——Mar 6, 2026
VICTOR MIRIAMEOfficerSell1.9k$97.13$181kFeb 24, 2026
VICTOR MIRIAMEOfficerExercise1.9k$95.74$178kFeb 24, 2026
MCMURRY-HEATH MICHELLEDirectorSell600$97.26$58kFeb 23, 2026
SINGH PRAHLAD RChief Executive OfficerSell25.5k$99.02$2.56MFeb 5, 2026

Analyst Notes

Sign in to write

No analyst notes on RVTY yet.

Analyst Ratings

16 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current061200Hold2.67
1 mo ago061100Hold2.65
2 mo ago061100Hold2.65
3 mo ago061100Hold2.65
Price target$125.25$100.00 – $165.00
+1.1% to target